Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1978 1
1979 2
1980 2
1981 1
1982 4
1983 3
1984 4
1985 1
1987 1
1988 1
1991 1
1994 1
1995 2
1996 3
1997 3
1998 4
1999 2
2000 3
2001 6
2002 1
2003 6
2004 6
2005 12
2006 13
2007 14
2008 24
2009 10
2010 16
2011 17
2012 11
2013 19
2014 28
2015 33
2016 28
2017 23
2018 27
2019 26
2020 36
2021 30
2022 30
2023 16
2024 17
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Results by year

Filters applied: . Clear all
Page 1
Response.
van Baar ACG, Bergman JJGHM. van Baar ACG, et al. Among authors: bergman jjghm. Gastrointest Endosc. 2022 Nov;96(5):875-876. doi: 10.1016/j.gie.2022.07.032. Gastrointest Endosc. 2022. PMID: 36270709 No abstract available.
Response.
Pouw RE, Belghazi K, Bisschops R, Bergman JJGHM. Pouw RE, et al. Among authors: bergman jjghm. Gastrointest Endosc. 2020 Feb;91(2):457. doi: 10.1016/j.gie.2019.10.014. Epub 2020 Jan 22. Gastrointest Endosc. 2020. PMID: 32036953 No abstract available.
Response.
van Munster SN, Pouw RE, Bergman JJGHM. van Munster SN, et al. Among authors: bergman jjghm. Gastrointest Endosc. 2020 May;91(5):1220. doi: 10.1016/j.gie.2020.02.014. Gastrointest Endosc. 2020. PMID: 32327127 No abstract available.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
van den Ende T, de Clercq NC, van Berge Henegouwen MI, Gisbertz SS, Geijsen ED, Verhoeven RHA, Meijer SL, Schokker S, Dings MPG, Bergman JJGHM, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Nieuwdorp M, de Gruijl TD, Soeratram TTD, Ylstra B, van Grieken NCT, Bijlsma MF, Hulshof MCCM, van Laarhoven HWM. van den Ende T, et al. Among authors: bergman jjghm. Clin Cancer Res. 2021 Jun 15;27(12):3351-3359. doi: 10.1158/1078-0432.CCR-20-4443. Epub 2021 Jan 27. Clin Cancer Res. 2021. PMID: 33504550 Clinical Trial.
Expected value of artificial intelligence in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
Messmann H, Bisschops R, Antonelli G, Libânio D, Sinonquel P, Abdelrahim M, Ahmad OF, Areia M, Bergman JJGHM, Bhandari P, Boskoski I, Dekker E, Domagk D, Ebigbo A, Eelbode T, Eliakim R, Häfner M, Haidry RJ, Jover R, Kaminski MF, Kuvaev R, Mori Y, Palazzo M, Repici A, Rondonotti E, Rutter MD, Saito Y, Sharma P, Spada C, Spadaccini M, Veitch A, Gralnek IM, Hassan C, Dinis-Ribeiro M. Messmann H, et al. Among authors: bergman jjghm. Endoscopy. 2022 Dec;54(12):1211-1231. doi: 10.1055/a-1950-5694. Epub 2022 Oct 21. Endoscopy. 2022. PMID: 36270318 Free article.
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
Kootte RS, Levin E, Salojärvi J, Smits LP, Hartstra AV, Udayappan SD, Hermes G, Bouter KE, Koopen AM, Holst JJ, Knop FK, Blaak EE, Zhao J, Smidt H, Harms AC, Hankemeijer T, Bergman JJGHM, Romijn HA, Schaap FG, Olde Damink SWM, Ackermans MT, Dallinga-Thie GM, Zoetendal E, de Vos WM, Serlie MJ, Stroes ESG, Groen AK, Nieuwdorp M. Kootte RS, et al. Among authors: bergman jjghm. Cell Metab. 2017 Oct 3;26(4):611-619.e6. doi: 10.1016/j.cmet.2017.09.008. Cell Metab. 2017. PMID: 28978426 Free article.
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.
Mingrone G, van Baar AC, Devière J, Hopkins D, Moura E, Cercato C, Rajagopalan H, Lopez-Talavera JC, White K, Bhambhani V, Costamagna G, Haidry R, Grecco E, Galvao Neto M, Aithal G, Repici A, Hayee B, Haji A, Morris AJ, Bisschops R, Chouhan MD, Sakai NS, Bhatt DL, Sanyal AJ, Bergman JJGHM; Investigators of the REVITA-2 Study. Mingrone G, et al. Among authors: bergman jjghm. Gut. 2022 Feb;71(2):254-264. doi: 10.1136/gutjnl-2020-323608. Epub 2021 Feb 17. Gut. 2022. PMID: 33597157 Free PMC article. Clinical Trial.
Advances in Endoscopic Therapy.
Bergman JJ, Yachimski PS. Bergman JJ, et al. Gastroenterology. 2018 May;154(7):1859-1860. doi: 10.1053/j.gastro.2018.04.007. Epub 2018 Apr 11. Gastroenterology. 2018. PMID: 29653148 Review. No abstract available.
Endoscopic treatment of early esophageal adenocarcinoma.
Milano RV, Bergman JJ, Pouw RE. Milano RV, et al. Among authors: bergman jj. Minerva Chir. 2018 Aug;73(4):355-365. doi: 10.23736/S0026-4733.18.07764-7. Epub 2018 May 24. Minerva Chir. 2018. PMID: 29795070 Free article. Review.
412 results